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Novel experimental results in human cardiac electrophysiology:
measurement of the Purkinje ﬁbre action potential from the
undiseased human heart1
Norbert Nagy, Tamás Szél, Norbert Jost, András Tóth, Julius Gy. Papp, and András Varró
Abstract: Data obtained from canine cardiac electrophysiology studies are often extrapolated to the human heart. However, it
was earlier demonstrated that because of the lower density of its K+ currents, the human ventricular action potential has a less
extensive repolarization reserve. Since the relevance of canine data to the human heart has not yet been fully clariﬁed, the aim
of the present study was to determine for the ﬁrst time the action potentials of undiseased human Purkinje ﬁbres (PFs) and to
compare them directly with those of dog PFs. All measurements were performed at 37 °C using the conventional microelectrode
technique. At a stimulation rate of 1 Hz, the plateau potential of human PFs is more positive (8.0 ± 1.8 vs 8.6 ± 3.4mV, n = 7), while
the amplitude of the spike is less pronounced. The maximal rate of depolarization is signiﬁcantly lower in human PKs than in
canine PFs (406.7 ± 62 vs 643 ± 36 V/s, respectively, n = 7). We assume that the appreciable difference in the protein expression
proﬁles of the 2 species may underlie these important disparities. Therefore, caution is advised when canine PF data are
extrapolated to humans, and further experiments are required to investigate the characteristics of human PF repolarization and
its possible role in arrhythmogenesis.
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Résumé : Les données recueillies d’études en électrophysiologie cardiaque chez le chien sont souvent extrapolées a` l’humain.
Cependant, il a été démontré précédemment que, en conséquence de la densité plus faible de ses courants K+, le potentiel
d’action ventriculaire humain possède une réserve de repolarisationmoins importante. Puisque la pertinence des données chez
le chien au cœur humain n’a pas encore été pleinement clariﬁée, le but de l’étude présente était d’établir pour la première fois
les potentiels d’action des ﬁbres de Purkinje (FP) humaines saines et de les comparer directement a` ceux du chien. Toutes les
mesures ont été réalisées a` 37 °C a` l’aide d’une méthode conventionnelle par microélectrode. À un taux de stimulation de 1 Hz,
le potentiel plateau des FP humaines est davantage positif (8,0 ± 1,8 vs 8,6 ± 3,4 mV, n = 7), alors que l’amplitude de la pointe est
moins prononcée. Le taux maximal de dépolarisation est signiﬁcativement plus faible chez les FP humaines comparativement a`
celles du chien (406,7 ± 62 vs 643 ± 36 V/s, n = 7). Les auteurs assument que la différence appréciable des proﬁles d’expression
protéique entre les deux espèces peut sous-tendre ces disparités importantes. La prudence est ainsi de mise lorsque des données
obtenues dans les FP de chien sont extrapolées aux humains, et des expériences plus approfondies sont requises aﬁn d’examiner
les caractéristiques de la repolarisation des FP humaines et leur rôle possible dans l’arythmogenèse. [Traduit par la Rédaction]
Mots-clés : humain, chien, ﬁbre de Purkinje, ventricule, potentiel d’action, électrophysiologie.
Introduction
The cardiac Purkinje ﬁbre (PF) system plays an important role in
impulse propagation and in the generation of cardiac arrhythmias
(Aiello et al. 2002; Han et al. 2002). It seems to be particularly
important in initiating transmural re-entry leading to torsades de
pointes arrhythmias, often associated with long QT syndromes
(Nattel et al. 2007). PFs may also play a role in the ventricular
arrhythmias induced by delayed afterdepolarizations (DADs), in-
traventricular re-entry, and ventricular ﬁbrillation.
Earlier electrophysiological studies demonstrated the PF action
potentials from different species, describing their morphology
and responses to pharmacological interventions (Attwell et al.
1979; Coraboeuf et al. 1979; Marban and Wier 1985; Varro et al.
1985a, 1985b; Noble 1986; Bril andMan 1989; Lathrop andVarro 1989;
Campbell et al. 1991). In spite of these studies, the lack of pub-
lished data on undiseased human PF action potentials means
that only very limited information is available concerning the
underlying transmembrane ionic currents and channel expres-
sions.
From earlier examinations of the importance of the repolariza-
tion reserve in canine PFs (Roden 1998), we concluded that the role
of the slow component of the delayed rectiﬁer K+ current (IKs) in
the PF (and in the ventricular muscle) under normal conditions is
minimal (Varro et al. 2000). However, in the event of an increased
action potential duration (APD), the enhanced IKs reduces the
proarrhythmic risk, providing an important safety factor in repo-
larization (Varro et al. 2000; Jost et al. 2005, 2007). Nagy et al.
(2004) and Jost et al. (2013) demonstrated an important role for the
sodium–calcium exchanger (NCX) in PF DADs, since the latter
were completely eliminated by the application of NCX inhibitors:
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SEA0400 and a novel compound ORM-10103. The ﬁrst reported
investigation of protein expression level in the canine heart (Han
et al. 2002) demonstrated that the ion channel expression in the
PFs, consistent with their diverging electrophysiological charac-
teristics, differs considerably from that in the ventricular muscle.
The ﬁrst data on the ion channel protein expression in human PFs
were presented by Gaborit et al. (2007). PF cellular electrophysio-
logical data from the levels of expression of channel proteins to
current analysis and basic pharmacological responses were re-
viewed by Boyden et al. (2010). The characteristics of the inward
rectiﬁer K+ current (IK1) and transient outward K+ current (Ito) in
Purkinje cells of the failing human heart were described by Han
et al. (2002). The most important ﬁndings were that the IK1 densi-
ties in the PFs and ventricular cells were comparable, in the range
of −110 to 0 mV, and that the Ito characteristics (i.e., recovery,
4-aminopyridine sensitivity) of human PFswere similar to those of
canine PFs. The sustained 4-aminopyridine-sensitive current mea-
sured after Ito inactivation was larger in human than canine Pur-
kinje cells. It was concluded that the sustained current in human
Purkinje cells is a noninactivating or only slowly inactivating
component of Ito.
It is generally believed that in cardiac electrophysiology, the
dog serves as a reasonably good model for humans. Indeed, in
accordance with this belief, the characteristics of the transmem-
brane ion channels (IKs, Ito, IK1, and the rapid component of the
delayed rectiﬁer K+ current (IKr)) are comparable in canine and
human ventricular myocytes (Varro et al. 1993; Wettwer et al.
1994; Magyar et al. 2000; Virag et al. 2001; Volders et al. 2003; Akar
et al. 2004; Jost et al. 2005). However, a recent study led us to
conclude that as a consequence of the smaller magnitudes of IK1
and IKs, the repolarization reserve in the human heart is signiﬁ-
cantly weaker (Jost et al. 2013), which results in important differ-
ences in drug responses between dogs and humans. Therefore,
care must be taken in extrapolating canine data to humans, since
the possibility that such discrepancies may also exist between
canine and human PF action potentials cannot be ruled out. Thus,
the aim of our present study was to provide direct experimental
data on action potentials in undiseased human PFs and to com-
pare these data with those for dog PFs.
Methods
The canine experiments were performed in compliance with
the Guide for the Care and Use of Laboratory Animals (USA NIH publi-
cation No. 86-23, revised 1985). All canine experimental protocols
were approved by the Ethical Committee for Protection of Ani-
mals in Research of the University of Szeged, Hungary (permit
No. I-74-9/2009). The investigations performed on human cardiac
samples conformed to the principles outlined in the Helsinki Dec-
laration. All human experimental protocols were approved by the
Regional and National Human Medical and Biological Research
Ethics Committee, University of Szeged (permit No. 63/1997).
Human PF preparations
Undiseased hearts (n = 7) obtained from organ donors were ex-
planted to obtain pulmonary and aortic valves for transplant sur-
gery. Before cardiac explantation, the donors had not received
medication other than furosemide, dobutamine, and plasma ex-
panders. White free-running PFs with the attached ventricular
tissue were excised from the right ventricle (Fig. 1). Similar
preparations were obtained from the right ventricle of dogs
(weighing 10–15 kg) previously anesthetized intravenously with
30 mg pentobarbital/kg.
Recording action potentials in multicellular PFs
Action potentials from PFs were recorded at 37 °C by using
conventional microelectrode techniques. The preparations were
mounted in a custom-made plexiglass chamber, allowing con-
tinuous superfusion with CO2-saturated Krebs–Henseleit solu-
tion (containing 118.5 mmol/L NaCl, 4 mmol/L KCl, 1.2 mmol/L
NaH2PO4, 25 mmol/L NaHCO3, 1 mmol/L MgSO4, 11 mmol/L glu-
cose, 1.8 mmol/L CaCl2; the pH was set to 7.4 by bubbling with
CO2), and stimulated with constant-current pulses of 1 ms dura-
tion at a rate of 1 Hz through a pair of bipolar platinum electrodes,
using an electrostimulator (Hugo Sachs Elektronik, model 215/II).
During the rate-dependent protocol, the preparations were stim-
ulated by 10 pulses at each frequency. A complex, electrically
coupled PF–ventricle preparation was used to perform experi-
ments with 2 microelectrodes. In this case, the sample was stim-
ulated from the ventricular side (Fig. 1). Sharp microelectrodes,
with a tip resistance of 10–20 M when ﬁlled with 3 mol/L KCl,
were connected to an ampliﬁer (Biologic Ampliﬁer,model VF 102).
The voltage output from the ampliﬁer was sampled by using an
AD converter (NI 6025, Unisip Ltd.). APDs determined at 90% and
50% levels of repolarization (APD90 and APD50) were obtained by
using the custom-made HSE-APES and Evokewave version 1.49
(Unisip Ltd.) software. Efforts were made to maintain the same
impalement throughout each experiment.
Statistics
All values presented are arithmetic means ± SE. Statistical sig-
niﬁcance of differences was evaluated by using Student’s t test for
paired or unpaired data, as relevant. Differences were considered
signiﬁcant when the p value was <0.05.
The beat-to-beat variabilities (BVRs) of APD90 and APD50 were
calculated by the analysis of 40 consecutive action potentials from
the steady-state sections, using the following formulas:
BVRAPD90  (APD90; i  1  APD90; i)(nbeatsx2)
BVRAPD50  (APD50; i  1  APD50; i)(nbeatsx2)
Since we compare data both within and between species, the
statistical analysis of BVR was performed by one-way ANOVA.
Results
Frequency-dependent behavior of PF APD90 and Vmax
The frequency-dependent changes in APD90 and Vmax weremea-
sured by applying a stimulus pattern from 400 to 5000 ms cycle
length in human (Fig. 2A) and canine (Fig. 2B) PFs. The frequency-
dependent changes in APD90 were identical in the 2 types of PFs
(Fig. 2C). In the individual human experiments (Fig. 2D), the rate
dependence reveals considerable variation in the APD values at
Fig. 1. Human or dog Purkinje ﬁbre (PF) preparation in the tissue
bath (A), and a schematic diagram of the experimental arrangement
of the measurement with one conventional electrode (A) and
2 electrodes (B). In the latter case, the ventricular part of the tissue
was larger to provide sufﬁcient area for electrode impalement.
Abbreviations: S, stimulus electrode; M1, microelectrode measuring
the action potential from the ventricular tissue; M2, microelectrode
measuring the action potential from the PF.
M1
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S
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SM1
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1000 ms, whereas relatively similar frequency-dependent behav-
ior was observed.
The frequency-dependent characteristic of Vmax was also simi-
lar in both cases, except that the depolarization rate was signiﬁ-
cantly lower in humans than in canines (Fig. 2E).
Analysis of PF phase 1 repolarization
The PF action potential was measured from right ventricular
free-running PFs of both dogs and humans. The main difference
was the lack of a pronounced phase 1 repolarization (action
potential spike) for humans, and the plateau level was there-
fore higher. Moreover, the action potential spike amplitude was
markedly smaller than that for dogs (Fig. 3) (9.8 ± 3.4 mV for
humans vs 34.2 ± 2.8 mV for dogs, p < 0.05, n = 7). The slope decay
of the action potential spike was estimated by using standard
exponential ﬁtting with 1 term, but we did not ﬁnd a signiﬁcant
difference between the tau values of the 2 species (1.77 ± 0.42 ms
for humans vs 2.1 ± 0.17 ms for dogs, n = 7).
Analysis of the PF plateau level
As a possible consequence of the previous result, the plateau
characteristic of the action potential in human PFs was signiﬁ-
cantly different from that in canine PFs. The mid-plateau voltage
level (Fig. 4), whichwasmeasured at the half-time of APD90, was in
the positive voltage range (8.0 ± 1.8 mV) for humans, but for dogs
it was in the negative voltage range (−8.6 ± 3.4 mV, p < 0.05, n = 7).
The slope measured as the time derivative of the plateau voltage
was steeper for humans than for dogs (−0.195 ± 0.2 mV/ms for
humans vs −0.09 ± 0.01 mV/ms for dogs, p < 0.05, n = 7; Fig. 4).
Parallel measurements of ventricular and PF action
potentials
Simultaneous measurements of the ventricular and PF action
potentials were carried out by the technique with 2 conven-
tional microelectrodes to assess the APD90 dispersion between
the 2 adjacent regions. The PF–ventricular dispersion was calcu-
lated by subtracting the PF APD90 from the respective ventricular
APD90. It proved to be 128 ± 5.1ms (n = 7) for dogs vs 59 ± 20ms (n = 2)
for humans at the same stimulation frequency of 1 Hz. Although
the number of observations for human PF preparations is low,
which is an obvious limitation, the data appear to suggest a lower
dispersion rate in humans, which could be a consequence of the
Fig. 2. Comparison of characteristics of human (A) and dog (B) action potentials. The spike-and-dome conﬁguration is pronounced in the dog
but less so in the human case. Further, the human plateau potential, unlike that in the dog, is in the positive voltage range. The right side of
the ﬁgure shows the corresponding mean of the frequency-dependent action potential duration (APD90) values (C), the rate-dependent
behavior of individual human preparations (D), and the Vmax values (E) (data are means ± SE, p < 0.05, n = 7 from 7 hearts).
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“ventricular-like” shape of the human PF action potential (Figs. 5A
and 5B).
Analysis of BVRs of APD90 and APD50
The short-term variability of APD was calculated by the analysis
of 40 consecutive action potentials applying the formulas de-
scribed in the Statistics section of Methods. The variability in a
representative experiment was depicted in a Poincaré plot (Figs. 6A
and 6B), where each APD value was plotted against the previous
action potential. Within a species, we did not ﬁnd a signiﬁcant
difference between the variabilities of APD90 andAPD50 (1.12 ± 0.16
and 0.87 ± 0.21 ms, respectively, for humans; 2.09 ± 0.69 and 2.5 ±
0.68 ms, respectively, for dogs; one-way ANOVA). At the same
time, we observed a signiﬁcantly lower BVR of APD50 for humans
than for dogs (Fig. 6C).
Discussion
The goal of this study was to evaluate the characteristics of the
human Purkinje action potentials recorded from free-running PFs
obtained from undiseased donor hearts and to compare them
with the corresponding canine data. We are not aware of any
previous study of the action potential of undiseased human PFs in
intact tissue.
Ourmajor ﬁnding is that the shape of the PF action potential for
humans is more “ventricular-like” than that for dogs, with the
former having a smaller spike amplitude and a less steep plateau
phase, which is in a more positive membrane potential range in
humans than in dogs.We speculate that this special characteristic
of the human PF action potential may be a consequence of the
differing channel protein composition and a function of the Pur-
kinje cells and (or) human PFs containing ventricular cells, which
inﬂuence the PFs electrotonically. To explore this issue, further
morphological and (or) single-cell experiments are required.
What are the consequences of the shape of the human PF
action potential?
Several studies have led to the claim that the dispersion rate
between the ventricular and PF APDs could be harmful if K+ chan-
nel inhibitors lengthen the ventricular and PF action potentials to
different extents, with the result that a potentially arrhythmo-
genic dispersion can build up (Antzelevitch 2008). Furthermore,
the effect of an inherited genetic mutation in a channel protein
Fig. 3. A comparison of human (A) and dog (B) spike morphology and amplitude. The magnitude of the action potential spike is more than
2-fold higher in dogs, as illustrated in panel C. The amplitudes of the spikes were calculated from the maximal point of action potential
upstroke to the end-point of phase 1 repolarization (data are means ± SE, p < 0.05, n = 7 from 7 hearts).
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(e.g., LQT mutations), which has a negligible impact on the action
potential under basic conditions, could be augmented under a K+
channel blockade, especially during slow pacing. It may be feasi-
ble to assume that the somewhat enhanced ventricular-type char-
acteristics of the human PF action potential could result in a lower
dispersion rate between the ventricle and the PFs in humans com-
pared with dogs.
A further possible consequence of the shape of the human PF
action potential could be an increased repolarization reserve,
since the higher mid-potential of the plateau level may increase
the activation of both IKr and IKs, leading to their enhanced con-
tribution to the repolarization process.
Possible consequences of the shape of the PF action
potential on the repolarization reserve
We previously compared human and dog ventricular repolar-
ization reserves and found a lower repolarization capacity in hu-
mans due to the reduced activities of IK1 and IKs (Jost et al. 2013).
This causes a greater level of response of the ventricular action
potential in humans than in dogs to the same pharmacological
intervention.
The repolarization reserves of human and canine PFs may
display both similarities and differences. We suggest that IK1 is
weaker in human PFs than in canine PFs (Gaborit et al. 2007) and,
therefore, attenuates the PF repolarization capacity. At the same
time, the higher plateau level of the human PF action potential
may also inﬂuence the kinetics of the K+ currents, i.e., the elevated
activating potential may generate increased current amplitudes,
which may exert the opposite effect on the extent of repolariza-
tion.
Interestingly, the IK1 density in the PFs in the failing human
heart has been reported to be comparable with that in the ventri-
cle (Han et al. 2002), while IK1 in the PFs in the undiseased heart
was about one-third inmagnitude of that in the ventricle (Gaborit
et al. 2007). The question arises of whether, in spite of the well-
known IK1 downregulation in ventricular remodeling, IK1 in the
PFs is upregulated in heart failure (Nattel et al. 2007).
Comparison of human and canine Purkinje action
potentials
We set out to compare human and canine Purkinje action po-
tentials, but since data are not available on ionic currents in hu-
man PFs, we decided to compare protein expression levels in the
2 species.
Sodium current
The Purkinje action potentials display a very fast upstroke in
phase 0. In dogs, the underlying current is carried by the Nav1.5
current, which demonstrates relatively low tetrodotoxin (TTX)
sensitivity (Gintant et al. 1984). Since both the ventricular and PF
action potentials in dogs are abbreviated by a low concentration
of TTX, the noncardiac, TTX-sensitive channels have also been
Fig. 4. Analysis of the action potential plateau phases, with calculation of the mid-plateau level at the half-point of action potential duration
(APD90), and the plateau slope measured as the time derivative of the plateau voltage (A). In all measurements, the Purkinje ﬁbre (PF) plateau
for humans reached a signiﬁcantly higher potential than that for dogs (B). For humans the plateau has a steeper voltage (C), so that its
derivative was higher than that calculated for dogs. Data are means ± SE, p < 0.05, n = 7 from 7 hearts.
Results – Comparison of human and dog Purkinje plateau level and slope
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suggested to contribute to sodium current in both preparations.
While the canine ventricle displays neuronal Na+-channel iso-
forms Nav1.2, Nav1.3, and Nav1.6, the PFs express Nav1.1 and
Nav1.2, both noncardiac isoforms (Boyden et al. 2010). Human PFs
express Nav1.5 at a level similar to that expressed in dog PFs (Han
et al. 2002; Gaborit et al. 2007); accordingly, the observed action
potential amplitudes were identical in the 2 species, though the
rate of depolarization was found higher in dogs (Fig. 2E). The
underlying mechanism could involve different Na+-channel iso-
forms and (or) kinetics in humans. However, if human PFs contain
electrotonically coupled ventricular cells, the rate of action poten-
tial upstroke could be markedly reduced via the considerably
slower kinetics of ventricular depolarization.
Ca2+ handling
In humans, the levels of the investigated Ca2+-handling proteins
NCX1, SERCA2, CASQ2, and RYR2 were previously found to be
lower in the PFs than in the ventricle (Gaborit et al. 2007). These
reduced expression levels were suggested to be related to the
lower contractile ability of the PFs. Similarly, L-type Ca2+ current
in the canine PFs was markedly reduced, relative to that in the
ventricle, whereas the level of T-type Ca2+ current expression was
nearly identical to that of L-type Ca2+ current. The lower level of
NCX1 expression in the dog was assumed to be responsible for the
increased digitalis sensitivity of the canine PFs (Han et al. 2002). In
line with this, it was demonstrated that NCX inhibition can effec-
tively decrease the DADs in the canine PFs, suggesting an impor-
tant role for NCX in arrhythmogenesis (Nagy et al. 2004; Jost et al.
2013). Unfortunately, similar data from human PF preparations
are not available.
Transient outward current
Like in the human ventricle, Ito in human PF cells is primarily
generated by the voltage-gated K+ (Kv) channels 4.3, 1.4, 1.5, and
3.4. Furthermore, the expression of the Kv4.3 subunit has been
found to be abundant, while the expression of KChIP2 (Kv channel-
interacting protein 2) proved to be low in both human and canine
Purkinje cells (Gaborit et al. 2007). This result was consistent with
the ﬁnding of Han et al. (2002), who found a very slow recovery of
canine Ito from inactivation. Conversely, KChAP (Kv channel-
associated protein) and DP6 exhibited high expression in the Pur-
kinje cells (Kuryshev et al. 2001; Xiao et al. 2013). These proteins
seem to play no physiological role in the ventricular tissue. In
contrast, Xiao et al. (2013) assume that KChAP may play a physio-
logical role in the Purkinje Ito.
Despite the similarities in the expression proﬁles of the Ca2+-
handling proteins and the channel and accessory proteins of Ito,
marked differences were found between the 2 species in spike-
and-dome morphology. This discrepancy may be underlined by
differences in the Ca2+ current and (or) the electrophysiological
characteristic of Ito. Since there is a marked difference between
the Purkinje and ventricle spike amplitudes in dogs, the question
again arises of whether the small spike observed in human PFs
could be a consequence of electrotonically coupled ventricular
cells in these PFs.
Delayed rectiﬁer currents
The demonstration of delayed rectiﬁer currents in single Pur-
kinje cells is difﬁcult because of the sensitivity of IK to cell isola-
tion, but IKr and IKs data from human PF preparations are not
available. Nonetheless, there is an interesting difference between
Fig. 5. Parallel measurements of ventricular (up) and Purkinje (down) action potentials with 2 microelectrodes to analyze the actin potential
duration (APD90) dispersion in humans (A) and dogs (B). Although there were only 2 human measurements, it is apparent that the dispersion
was lower for humans (n = 7 from 7 dog hearts, n = 2 from 2 human hearts).
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humans and dogs in the levels of expression of proteins related to
the delayed rectiﬁers. In dogs, the levels of the ERG, KvLQT1, and
MinK proteins were signiﬁcantly lower in the PFs than in the
ventricle, which may explain the lower magnitude of IKr and IKs
and may contribute to the longer APD90 in the PFs. However, in
humans, where the APD in the PFs is also longer than in the
ventricle, the expression of the levels of HERG and KvLQT1 pro-
teins were found to be similar to those in the ventricle (Han et al.
2002; Gaborit et al. 2007), suggesting that additional mechanisms
may contribute to the longer APD. A promising candidate could be
IK1, the level of expression of which has been found to be lower
than that in the ventricle (Gaborit et al. 2007).
At the same time, the data obtained from protein expression
analysis may imply the enhanced function of IKr and IKs in human
PFs, which may increase the repolarization reserve and might
explain the lower APD50 variability of human PFs as compared
with canine PFs (see Fig. 6).
Inward rectiﬁers
Inward rectiﬁers, including IK1 (Kir2.1, Kir2.2, and Kir2.3), IK(ATP)
(Kir6.1 and Kir6.2), and IK(Ach) (Kir3.1 and Kir3.4) carry K+ currents,
which have important roles in the ﬁnal phase of the repolariza-
tion and in setting the level of the resting membrane potential.
The level of expression of Kir2.x in human PFs has been reported
to be lower than that in the ventricle (Gaborit et al. 2007). We
previously demonstrated a lower repolarization reserve in human
ventricle than in canine ventricle (Jost et al. 2013), and concluded
that this mechanism is due in part to the reduced level of expres-
sion of IK1 proteins in humans. Since human PFs express a lower
level of Kir2.x than that in the ventricle, it may attenuate the
repolarization capacity of human PFs and may enhance the beat-
to-beat APD variability. However, the observed resting membrane
potential (−85.03 ± 1.9 mV) does not indicate a marked reduction
in IK1. In line with this, the temporal variability of APD90 was
lower in human PFs, though the differences were insigniﬁcant
and remained within the experimental variance (Fig. 6).
Fig. 6. Analysis of the beat-to-beat variabilities of action potential duration (APD90) and APD50. Panels A and B depict the APD90 (upper panels)
and APD50 (lower panels) variabilities collected from 40 consecutive action potentials by using Poincaré plots in humans (A) and in dogs (B).
Statistical analysis did not reveal a signiﬁcant difference between the APD values (C) within the same species, but there was a signiﬁcant
difference in APD50 variability between the 2 species. Data are means ± SE, p < 0.05, n = 7–7 from 7 hearts in each species.
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Conclusions and future perspectives
To the best of our knowledge, this is the ﬁrst study to provide AP
data on undiseased human PFs. Although human and canine PFs
exhibit numerous similarities in protein expression proﬁles, we
observed less “typical” Purkinje action potentials in humans.
These action potentials proved to be more similar to the ventricular
waveforms by having their plateau level in the positive membrane
potential range and displaying much reduced spike-and-dome mor-
phology. The waveform differences may have a role in the func-
tion of the human PF repolarization reserve and, therefore, may
inﬂuence the kinetics of various transmembrane ionic currents,
drug responses, and APD dispersion in several cardiac diseases.
Hence, it is important that care be taken in extrapolating to hu-
mans data obtained on canine PFs, and further studies are re-
quired with the aim of current analysis and determination of the
basic pharmacological properties of human PFs to achieve a better
understanding of the pathomechanisms of human arrhythmias
and to promote future antiarrhythmic drug development.
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